Clinical trials

  • Autologous CD19-directed CAR T cells for Relapsed or refractory CD19+ B-cell neoplasms | Acute lymphoblastic leukaemia (refractory) | Diffuse large B-cell lymphoma (refractory) | Mantle cell lymphoma (refractory)
  • CENEGERMIN for Traumatic brain injury (subacute, moderate to severe)
  • APIXABAN for Left ventricular thrombosis | Acute myocardial infarction
  • ACETYLCYSTEINE AMIDE for Mild cognitive impairment | Alzheimer's disease
  • UPADACITINIB for Long COVID
  • UPADACITINIB for Polymyositis|Dermatomyositis|Antisynthetase syndrome|Overlap myositis|Immune-mediated necrotizing myopathy
  • UBLITUXIMAB for Relapsing multiple sclerosis
  • ZODASIRAN for Homozygous familial hypercholesterolemia
  • SACITUZUMAB GOVITECAN for Resectable non-small cell lung cancer | Non-small cell lung cancer
  • AROG4-01 for Advanced refractory solid tumors
  • Frexalimab for Kidney transplant rejection
  • LY3537982 for Non-small cell lung cancer (KRAS G12C-mutant)